Hypocholesterolemic Effect of Fibracep

Validation Study of the Effects of FIBRACEP Supplementation on the Lipid Profile

FIBRACEP is an onion based fiber that has demonstrated in vitro and in animal models the capacity to increase HDL cholesterol levels as well to improve other lipid profile species. This intervention aims to demonstrate FIBRACEP's blood lipid profile improvement effect. For that purpose, hypercholesterolemic subjects will be recruited and given a daily dose of 7 g of FIBRACEP for two months. Changes in blood lipid profile will be the end-point of the study.

Inclusion Criteria:

• Total cholesterol levels above 200 mg/dL, observed in at least 3 different days
• Body mass index between 25 and 35 (Overweight and obesity type 1 diagnosis)

Exclusion Criteria:

• Type 1 and Type 2 Diabetes
• Allergy to any compound described in FIBRACEP